✦ LIBER ✦

The ACE gene insertion/deletion polymorphism and elite endurance swimming

✍ Scribed by Georgios Tsianos; Julie Sanders; Sukhbir Dhamrait; Steve Humphries; Stan Grant; Hugh Montgomery

Publisher: Springer
Year: 2004
Tongue: English
Weight: 163 KB
Volume: 92
Category: Article
ISSN: 1439-6319
DOI: 10.1007/s00421-004-1120-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ACE gene insertion/deletion polymorphism

ACE gene insertion/deletion polymorphism and renal scarring in children with urinary tract infections

✍ Eleni Sekerli; Dimitrios Katsanidis; Norma Vavatsi; Areti Makedou; Magdalini Gat 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 186 KB

Elite endurance athletes and the ACE I a

Elite endurance athletes and the ACE I allele – the role of genes in athletic performance

✍ George Gayagay; Bing Yu; Brett Hambly; Tanya Boston; Alan Hahn; David S. Celerma 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 56 KB

Linkage mapping of the ovine ANLN gene u

Linkage mapping of the ovine ANLN gene using an insertion/deletion polymorphism

✍ C. Diez-Tascón; K. G. Dodds; A. Zadissa; A. M. Crawford 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

The combined impact of metabolic gene po

The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes

✍ Ildus I. Ahmetov; Alun G. Williams; Daniil V. Popov; Ekaterina V. Lyubaeva; Albi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 437 KB

The insertion/deletion polymorphism of t

The insertion/deletion polymorphism of the angiotensin-converting enzyme gene and the risk for restenosis after PTCA

✍ Henry Völzke; Sabine Hertwig; Rainer Rettig 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 706 KB

Renin-angiotensin system inhibitors, ang

Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer : The Rotterdam Study

✍ Ronald van der Knaap; Claire Siemes; Jan-Willem W. Coebergh; Cornelia M. van Dui 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract ## BACKGROUND. Angiotensin I‐converting enzyme (ACE) inhibitors, angiotensin II antagonists, and the ACE insertion/deletion (I/D) gene polymorphism all influence serum angiotensin II action. Because angiotensin II levels have been associated with cancer, the objective of the current ep